ORAGENICS INC (OGEN)
Data as of , from SEC Form 4 filings.
See up to 3 months of OGEN. The 7-day demo opens the 1M and 3M ranges and puts OGEN on your watchlist.
Start 7-day demoLatest OGEN insider trades
About ORAGENICS INC (OGEN)
ORAGENICS INC files with the SEC under CIK 0001174940 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
OGEN Form 4 activity by transaction type, last 90 days
No Form 4 activity for OGEN in the last 90 days.
OGEN insider transactions (Form 4)
117 Form 4 filings on record, the earliest from Dec 9, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Spencer - Officer | Grant or award | Employee Stock Option (right to buy) | 55,900 | $0.00 | - | |
| Fred Telling - Director | Open-market sale | Common Stock | 210 | $0.94 | $198 | |
| Fred Telling - Director | Grant or award | Non-Employee Director Option (Right to Buy) | 125,000 | $0.00 | - | |
| Odyssey Health, Inc. - 10% Owner | Open-market sale | Common Stock - OGEN | 2,000 | $4.46 | $9K | |
| Odyssey Health, Inc. - 10% Owner | Open-market sale | Common Stock - OGEN | 5,044 | $4.26 | $21K | |
| Odyssey Health, Inc. - 10% Owner | Open-market sale | Common Stock - OGEN | 5,000 | $4.27 | $21K | |
| Odyssey Health, Inc. - 10% Owner | Open-market sale | Common Stock - OGEN | 5,000 | $4.45 | $22K | |
| Robert C. Koski - Director | Other | Common Stock | 5,000 | - | - | |
| Robert C. Koski - Director | Other | Series B Convertible Preferred Stock | 1,500,000 | - | - | |
| Alan W. Dunton - Director | Open-market sale | Common Stock | 66 | $0.36 | $24 | |
| Fred Telling - Director | Open-market sale | Common Stock | 3,597 | $0.36 | $1K |
OGEN insider trading FAQ
What is the latest insider trade for OGEN?
ORAGENICS INC (OGEN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-07. The full record for OGEN runs to 7 Form 4 filings, the earliest from 2024-12-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OGEN stock?
No insider purchases of OGEN were filed in the last 90 days.
How many insiders are selling OGEN stock?
No insider sales of OGEN were filed in the last 90 days. 7 sales are on record for this company.
Where can I see OGEN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OGEN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Spencer view on EDGAR
- - Fred Telling view on EDGAR
- - Odyssey Health, Inc. view on EDGAR
- - Odyssey Health, Inc. view on EDGAR
- - Robert C. Koski view on EDGAR
- - Alan W. Dunton view on EDGAR
- - Fred Telling view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where OGEN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OGEN with a 7-day demo
- OGEN on your watchlist
- Every OGEN Form 4 filing on record
- Up to 3 months of OGEN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
